Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: European Union
Medicines price transparency: Ground still left to cover
Katrina Perehudoff
-
February 3, 2023
Wrapping up 2022 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 22, 2022
The EU proposed Covid waivers of certain TRIPS rules are mostly...
Medicines Law & Policy
-
October 14, 2021
Advanced Purchase Agreements for Covid-19 Vaccines: Do they ensure Global Public...
Medicines Law & Policy
-
July 21, 2021
Dutch Health Care Institute Says No to Medicines Pirate
Ellen 't Hoen
-
March 29, 2021
We need a Global Vaccines Taskforce, not just a British or...
Christopher Garrison
-
February 24, 2021
The European Commission says Covid-19 vaccines should be global public goods,...
Medicines Law & Policy
-
January 28, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Some Surprises in the European Commission’s New Intellectual Property Strategy
Ellen 't Hoen
-
December 2, 2020
Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to...
Medicines Law & Policy
-
May 29, 2020
1
2
Page 1 of 2
This work is licensed under Creative Commons.